MetaCap

Fortress Biotech Insider Trades

NASDAQ: FBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.09+0.05 (+2.45%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

After hours: 2.10 +0.48%

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Fortress Biotech insider activity

Over the last 12 months, Fortress Biotech insiders reported 10 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Jin David (Chief Financial Officer) reporting a transaction in 1,190 shares at $1.82 on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put FBIO's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

FBIO insider transactions

Fortress Biotech insider transactions
DateInsiderTypeSharesValueFiling
Oct 1, 2026Jin DavidChief Financial OfficerAward1,190$2.16KForm 4
Jun 22, 2026Jin DavidChief Financial OfficerAward400,000—Form 4
Apr 1, 2026Jin DavidChief Financial OfficerAward2,967$6.46KForm 4
Mar 18, 2026WEISS MICHAEL SExecutive Vice ChairmanAward475,424—Form 4
Mar 18, 2026ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMANAward475,424—Form 4
Jan 1, 2026LOBELL J JAYDirectorAward27,322—Form 4
Jan 1, 2026Hoenlein MalcolmDirectorAward27,322—Form 4
Jan 1, 2026Klein DovDirectorAward27,322—Form 4
Jan 1, 2026Lorenz KevinDirectorAward27,322—Form 4
Jan 1, 2026Harvey JimmieDirectorAward27,322—Form 4
Oct 1, 2025Jin DavidChief Financial OfficerAward2,711$3.55KForm 4
Apr 1, 2025Jin DavidChief Financial OfficerAward5,000$6.08KForm 4
Jan 1, 2025ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMANAward454,153—Form 4
Jan 1, 2025WEISS MICHAEL SExecutive Vice ChairmanAward454,153—Form 4
Jan 1, 2025Harvey JimmieDirectorAward49,383—Form 4
Jan 1, 2025Klein DovDirectorAward49,383—Form 4
Jan 1, 2025Hoenlein MalcolmDirectorAward49,383—Form 4
Jan 1, 2025Lorenz KevinDirectorAward49,383—Form 4
Jan 1, 2025Lu LucyDirectorAward49,383—Form 4
Jan 1, 2025LOBELL J JAYDirectorAward49,383—Form 4
Dec 19, 2024Jin DavidChief Financial OfficerAward1,000,000—Form 4
Oct 1, 2024Jin DavidChief Financial OfficerAward2,625$3.22KForm 4
Sep 23, 2024ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMANBuy763,359$1.40MForm 4
Jul 11, 2024ROSENWALD LINDSAY A MDPresident, CEO & ChairmanBuy5,000$37.42KForm 4
Jul 10, 2024Jin DavidChief Financial OfficerBuy500$3.75KForm 4
Jul 9, 2024ROSENWALD LINDSAY A MDPresident, CEO & ChairmanBuy5,000$36.97KForm 4
Jul 8, 2024ROSENWALD LINDSAY A MDPresident, CEO & ChairmanBuy5,000$36.76KForm 4
Jun 28, 2024ROSENWALD LINDSAY A MDPresident, CEO & ChairmanBuy20,000$32.72KForm 4
May 16, 2024ROSENWALD LINDSAY A MDPresident, CEO & ChairmanBuy10,000$17.59KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related